• Latest Posts
ADVERTISEMENT

Biogen acquiring Reata Pharmaceuticals for $7.3B

AbbVie takes step forward in Europe with migraine drug

New disease characteristic seen as NMD Pharma reports Charcot-Marie-Tooth results

PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases

New epilepsy study could lead to new treatment options

Sania Therapeutics launches to advance neural circuit dysfunction medicines

ADVERTISEMENT